Medicare Enrolled
Dr. Imran Iqbal, M.D.
Optician · Dallas, TX
Practice pattern: Mixed Practice
— Diverse clinical practice across multiple procedure types
Low-engagement
Very High
DATA COVERAGE
Data in 4 of 4 federal sources
Measures public federal data availability — not provider quality
Informational, not a quality rating.
This page presents federal public records about Dr. Iqbal from CMS (NPPES, Open Payments, Medicare Provider Utilization, PECOS). It is not medical advice, an endorsement, or a judgment of clinical quality. Always consult the provider directly and a licensed clinician for medical decisions. Read methodology →
Are you Dr. Iqbal?
Request a correction or review of any data shown here. Provider portal →
What this data tells you about Dr. Iqbal
Dr. Imran Iqbal is an optician specialist in Dallas, TX, with 20 years of NPI registration. Based on federal Medicare data, Dr. Iqbal performed 64,876 Medicare services across 4,031 unique beneficiaries.
Between the years covered by Open Payments, Dr. Iqbal received a total of $6,552 from 35 pharmaceutical and/or device companies across 395 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common in optician. Most payments are for meals and travel — low-value interactions common across virtually all practicing physicians. Patients may wish to discuss these relationships with their provider.
The Data Coverage level for Dr. Iqbal is Very High — reflecting how much public federal data is available about this provider. This is not a quality rating. Patients are encouraged to use this data as one of several factors when choosing a healthcare provider.
✓ 20 years in practice
▲ Top 1% volume in TX
$6,552 industry payments
Medicare Practice Summary
Medicare Utilization ↗64,876
Medicare services
Top 1% in TX for optician
4,031
Unique beneficiaries
$8
Avg. Medicare payment
Medicare patients only (65+ / disabled) · Not a quality rating · How to read this →
~3,244 Medicare services per year of practice
Top procedures by volume
Ranked by number of services performed for Medicare patients. Avg. submitted charge is what the provider billed; avg. Medicare payment is what CMS paid.
| Procedure | Volume | Avg. paid | Avg. submitted |
|---|---|---|---|
| Certolizumab injection (Cimzia) An injection of certolizumab pegol administered under the direct supervision of a physician. |
51,000 | $4 | $15 |
| Denosumab injection (Prolia/Xgeva) | 5,760 | $18 | $68 |
| Office visit, established patient (30-39 min) A follow-up office visit for an existing patient lasting between 30 and 39 minutes. The visit involves medical evaluation and management of the patient's condition. |
1,089 | $92 | $372 |
| Comprehensive metabolic blood panel A blood test that measures a group of chemicals, including glucose, electrolytes, and kidney and liver function markers. |
1,074 | $10 | $31 |
| Complete blood count (CBC) with differential An automated laboratory test that measures the levels of red blood cells, white blood cells, and platelets in the blood, including a breakdown of the different types of white blood cells. |
1,058 | $8 | $23 |
| Blood draw (venipuncture) Insertion of a needle into a vein to collect a blood sample. |
1,056 | $8 | $26 |
| C-reactive protein test (inflammation marker) A blood test that measures the level of C-reactive protein to detect the presence of infection or inflammation in the body. |
870 | $5 | $15 |
| Sed rate test (inflammation marker) This automated test measures how quickly red blood cells settle in a tube to detect inflammation in the body. |
809 | $3 | $8 |
| Non-hormonal chemotherapy injection This procedure involves administering non-hormonal anti-neoplastic chemotherapy medication via injection into the skin or muscle tissue. |
353 | $58 | $217 |
| Complement and antigen measurement A laboratory test to measure levels of complement proteins and antigens in the blood. |
172 | $12 | $36 |
| New patient office visit (45-59 min) An initial office visit for a new patient lasting between 45 and 59 minutes. This code covers the total time spent by the physician or qualified healthcare professional on the date of the encounter. |
153 | $123 | $491 |
| Urinalysis with microscopic exam A urine test performed manually that includes examining the sample under a microscope to check for abnormalities. |
126 | $3 | $9 |
| Uric acid level test A blood test that measures the level of uric acid in your body. Uric acid is a waste product formed when the body breaks down purines. |
124 | $4 | $13 |
| Autoimmune disorder antibody test A laboratory test that measures antibodies in the blood to help assess for autoimmune disorders. |
116 | $18 | $54 |
| Automated urinalysis An automated laboratory test performed on a urine sample to analyze its chemical and physical properties. The procedure uses machinery to detect various substances and cells within the urine. |
95 | $2 | $7 |
| Rheumatoid arthritis antibody test A blood test to measure antibodies used in assessing rheumatoid arthritis. |
90 | $13 | $39 |
| Rheumatoid factor level | 84 | $5 | $17 |
| Phosphate level test A blood test that measures the amount of phosphate in your body. Phosphate is a mineral that helps keep bones and teeth strong. |
79 | $5 | $14 |
| Vitamin D level test A blood test to measure the amount of Vitamin D-3 in your body. |
73 | $29 | $89 |
| Cardiac enzyme level (CK-MB) test A blood test that measures the total level of creatine kinase, specifically the cardiac enzyme fraction, to help evaluate heart muscle damage. |
70 | $6 | $20 |
| Hepatitis C antibody test A blood test that checks for antibodies to the hepatitis C virus. This test helps determine if a person has been exposed to the virus. |
66 | $14 | $43 |
| Hepatitis B core antibody test A blood test that measures the level of antibodies to the hepatitis B core antigen. This test helps determine if a person has been infected with the hepatitis B virus. |
64 | $12 | $36 |
| Hepatitis B surface antibody test A blood test that measures the level of antibodies against the hepatitis B surface antigen. This test is used to check for immunity to hepatitis B or to verify the effectiveness of the hepatitis B vaccine. |
64 | $11 | $32 |
| Hepatitis B surface antigen test A blood test that uses an immunoassay technique to detect the presence of the hepatitis B surface antigen. This test identifies whether the hepatitis B virus is currently present in the body. |
64 | $10 | $31 |
| X-ray of hand, minimum of 3 views An X-ray imaging test of the hand that captures at least three different angles to visualize the bones and joints. |
60 | $29 | $111 |
| Autoimmune disorder screening test A laboratory test used to screen for the presence of autoimmune disorders. |
56 | $12 | $36 |
| Screening test for antibody to noninfectious agent A laboratory test that screens for the presence of antibodies produced in response to a noninfectious agent. |
48 | $12 | $36 |
| Cardiolipin antibody (tissue antibody) measurement | 30 | $25 | $76 |
| Shoulder X-ray, 2+ views An X-ray imaging test of the shoulder joint using at least two different angles to visualize the bones and surrounding structures. |
29 | $29 | $104 |
| Thyroid stimulating hormone (TSH) test A blood test that measures the level of thyroid stimulating hormone to evaluate thyroid function. |
29 | $16 | $50 |
| Office visit, established patient, complex (40-54 min) An office or outpatient visit for an existing patient lasting between 40 and 54 minutes. This level of service is determined by the total time spent on the date of the encounter. |
27 | $141 | $530 |
| Foot X-ray, 3+ views An X-ray imaging test of the foot that captures at least three different views to evaluate the bones and joints. |
26 | $28 | $103 |
| Office visit, established patient (20-29 min) An office visit for an existing patient lasting between 20 and 29 minutes. The visit involves medical evaluation and management of the patient's condition. |
23 | $66 | $268 |
| New patient office visit, complex (60-74 min) | 15 | $175 | $648 |
| Flu vaccine administration This procedure involves the administration of the influenza virus vaccine. It covers the process of delivering the vaccine to the patient. |
13 | $30 | $76 |
| Flu vaccine, high-dose High-dose seasonal influenza vaccine for adults aged 65 and older. Contains four times the antigen of standard-dose flu vaccines (60 mcg per strain), split-virus formulation, preservative-free, single-dose syringe. |
11 | $72 | $587 |
How to read this data: This reflects Medicare patients only (typically 65+). Payment amounts are what Medicare paid the provider, not your out-of-pocket cost. A higher procedure volume generally indicates more experience with that procedure.
Industry Payment Transparency
Open Payments through 2024 ↗$6,552
Total received (2018-2024)
Avg $936/year across 7 years
Top 23% in TX for optician
35
Companies
395
Individual payments
All payments are legal and publicly reported · Not evidence of wrongdoing · How to interpret →
Payment profile
Industry payments classified by relationship type. Not all payments are equal — research and consulting reflect different relationships than speaking programs or meals.
Meals & Travel
Food, beverages, travel, and lodging — typically low-value
$6,047 (92.3%)
Speaking / Promotional
Speaker programs, honoraria, and industry-sponsored educational events
$505 (7.7%)
Payment trend by year
Annual totals from pharmaceutical and medical device companies.
2024
$762
2023
$1,210
2022
$175
2021
$110
2020
$306
2019
$2,022
2018
$1,967
Payments by company (2024)
Consulting
Speaking
Meals & Travel
Research
AbbVie, Inc.
$1,146
Amgen Inc.
$607
ABBVIE INC.
$578
Janssen Biotech, Inc.
$497
PFIZER INC.
$465
GlaxoSmithKline, LLC.
$440
Genentech USA, Inc.
$398
Novartis Pharmaceuticals Corporation
$355
Horizon Therapeutics plc
$310
UCB, Inc.
$203
AstraZeneca Pharmaceuticals LP
$195
AbbVie Inc.
$158
Horizon Pharma plc
$127
MEDAC PHARMA, INC.
$120
Aurinia Pharma U.S., Inc.
$104
Celgene Corporation
$94
Lilly USA, LLC
$92
Fresenius Kabi USA, LLC
$75
Mallinckrodt Hospital Products Inc.
$72
Mallinckrodt Enterprises LLC
$67
E.R. Squibb & Sons, L.L.C.
$66
Flexion Therapeutics, Inc.
$52
Boehringer Ingelheim Pharmaceuticals, Inc.
$49
Sobi, Inc
$44
GENZYME CORPORATION
$43
Celltrion USA Inc.
$28
Merck Sharp & Dohme Corporation
$27
Kiniksa Pharmaceuticals, Ltd.
$25
Mallinckrodt LLC
$23
SCILEX PHARMACEUTICALS INC.
$20
ANI Pharmaceuticals, Inc.
$18
Janssen Scientific Affairs, LLC
$15
Ultragenyx Pharmaceutical Inc.
$14
Ferring Pharmaceuticals Inc.
$14
West-Ward Pharmaceuticals
$11
Top 3 companies account for 35.6% of total payments
Associated products mentioned in payments ›
ACTHAR · AMJEVITA · Actemra · Arcalyst · BENLYSTA · COSENTYX · CYLTEZO · Cimzia · Crysvita · DUEXIS · EUFLEXXA · EVENITY · Enbrel · HUMIRA · Humira · IDACIO · INFLECTRA · KEVZARA · KRYSTEXXA · Kineret · LUPKYNIS · LYRICA · Mitigare · ORENCIA · Otezla · PENNSAID · PURIFIED CORTROPHIN GEL · Prolia · RENFLEXIS · RINVOQ · Rasuvo · Rinvoq · Rituxan · SAPHNELO · SIMPONI · SIMPONI ARIA · SKYRIZI · STELARA · TALTZ · TAVNEOS · TREMFYA · VRAYLAR · XELJANZ · YUFLYMA · ZTLido · Zilretta
Should you be concerned? Payments from pharmaceutical and device companies are legal and common — 57% of U.S. physicians receive at least one. They often reflect legitimate consulting, research, or education. What matters is whether a recommended drug or device appears in your doctor's payment records. If so, consider asking your doctor about it. How to interpret this data →
Most payments (92%) are for meals and travel — low-value interactions that are common across virtually all practicing physicians.
Equivalent to $10 per 100 Medicare services performed
Geographic Context
Opticians within 10 mi
504
Per 100K population
19.4
County median income
$74,149
Nearest hospital
TEXAS HEALTH PRESBYTERIAN HOSPITAL DALLAS
0.0 mi
0.0 mi
Data Sources
| Provider Registry | ✓ NPPES | Weekly updates |
| Medicare Enrollment | ✓ PECOS | Monthly updates |
| Practice Data | ✓ Medicare Util. | Annual (CY lag) |
| Industry Payments | ✓ Open Payments | CY 2024 |
| Disciplinary History | — Not public | N/A |
This provider has data in 4 of 4 available federal datasets, with a Data Coverage level of Very High. This measures how much public data is available about a provider — not how good they are. How we calculate this →
Summary
Dr. Iqbal is a mixed practice specialist, with above-average Medicare volume (top 1% in TX), with low-engagement industry engagement, with 20 years of NPI registration.
This summary is auto-generated from federal data. It describes data availability and patterns — not clinical quality. Read our methodology →
Frequently Asked Questions
Is Dr. Iqbal experienced with certolizumab injection (cimzia)?
Based on Medicare claims data, Dr. Iqbal performed 51,000 certolizumab injection (cimzia) services. Research suggests that higher procedure volume is often associated with better outcomes, particularly for complex procedures. Note that Medicare data only captures patients aged 65 and older, so the total practice volume across all patients is likely higher.
Does Dr. Iqbal receive payments from pharmaceutical companies?
Yes. Dr. Iqbal received a total of $6,552 from 35 companies across 395 individual payments. These payments are legal, publicly disclosed under the federal Sunshine Act, and common among physicians — 57% of all U.S. physicians receive at least one industry payment. Patients may wish to ask their doctor about these relationships, especially if a recommended drug or device appears in the payment records.
How do Dr. Iqbal's costs compare to other opticians in Dallas?
Dr. Iqbal's average Medicare payment per service is $8. Note that these figures represent what Medicare pays, not your out-of-pocket cost, which depends on your specific insurance plan and deductible. Procedure-level data above shows both what was submitted and what Medicare paid for each service type.
What does Data Coverage mean?
Data Coverage (currently Very High for Dr. Iqbal) measures how much public federal data is available about a provider. It is not a quality rating. A "Very High" or "High" level means the provider has data across multiple federal sources (NPPES, PECOS, Medicare Utilization, Open Payments), indicating a long track record of practice, Medicare participation, and industry disclosure. A "Low" or "Moderate" level may simply mean the provider is newer, does not see Medicare patients, or has not received any industry payments — none of which are inherently negative. Read our full methodology →
Is this data up to date?
Each data source has its own update cycle. Provider registry data (NPPES) is updated weekly. Medicare enrollment (PECOS) is updated monthly. Medicare practice data has a ~2 year lag — the most recent available is typically 2 years prior. Industry payment data (Open Payments) is published annually, usually in June, covering the prior calendar year. We display the data date prominently on each section so you always know how current it is. See our data freshness policy →
Explore related providers
Same specialty & city
Opticians in Dallas
Browse opticians in Dallas ranked by procedure volume and transparency data.
Highest volume
Top Opticians in TX
Opticians ranked by total Medicare services performed statewide.
Industry payments
Pharma Payments to Opticians in TX
Which TX opticians receive the most from drug and device companies.
By company
AbbVie, Inc. Payments to Doctors
See all physicians who received payments from AbbVie, Inc.
By company
Amgen Inc. Payments to Doctors
See all physicians who received payments from Amgen Inc.
By company
ABBVIE INC. Payments to Doctors
See all physicians who received payments from ABBVIE INC.
About this page
All data on this page is sourced verbatim from public federal records published by the U.S. Centers for Medicare & Medicaid Services (CMS): NPPES ↗, Open Payments ↗, Medicare Provider Utilization ↗, and PECOS. Publication is mandated by the Physician Payments Sunshine Act (§6002 ACA, 42 U.S.C. §1320a-7h) and the Freedom of Information Act.
This page is not medical advice, an endorsement, a recommendation, or a quality rating. The Transparency Score measures data completeness — how much federal information exists for this provider — not clinical performance, patient outcomes, or quality of care. Always verify information directly with the provider and consult a licensed clinician before making medical decisions.
Provider corrections: Provider portal · Privacy questions: Privacy Policy · Terms: Terms of Use · Methodology: Methodology